SCHEMBL537884

SCHEMBL537884

CSc1nc2c3c(n1)N(Cc1ccccc1)CCC3NN2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 3/20 0.34
MAPT P10636 3/20 0.34
TSHR P16473 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
SRC P12931 4/20 0.33
PPARG P37231 2/20 0.33
ACHE P22303 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.32
NPY5R Q15761 1/20 0.32
GAA P10253 1/20 0.32
HSP90AA1 P07900 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 2/20 0.32
ABL1 P00519 1/20 0.31
LMNA P02545 1/20 0.31
FYN P06241 1/20 0.31
FLT3 P36888 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537858 0.87 PTGIR (0.39) ALDH1A1KDM4EMAPTSMN1; SMN2GAA
SCHEMBL2809963 0.82 KDM4E (0.37) ALDH1A1KDM4EMAPTTSHRNPSR1
SCHEMBL537988 0.82 ALDH1A1 (0.34) ALDH1A1KDM4EMAPTTSHRNPSR1
SCHEMBL538443 0.81 TLR7 (0.38) ALDH1A1NPSR1SMN1; SMN2POLB
SCHEMBL2811945 0.81 ACHE (0.38) ALDH1A1ACHESMN1; SMN2LMNA
SCHEMBL2808281 0.81 MAPK1 (0.40) ALDH1A1KDM4ENPSR1ACHESMN1; SMN2
SCHEMBL2809502 0.81 HTR6 (0.41) ALDH1A1KDM4E
SCHEMBL538301 0.80 KDM4E (0.39) ALDH1A1KDM4EMAPTSMN1; SMN2NPY5R
SCHEMBL2812041 0.80 CASP1 (0.40) ALDH1A1KDM4ETSHRNPSR1NPY5R
SCHEMBL2812365 0.79 DRD4 (0.39) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
EP-2414359-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-02-08 EP disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 ALDH1A1 924/4885KDM4E 2749/4885MAPT 2947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.